U.S. Looks to Limit Out-of-Pocket Costs for Insulin Under Medicare
The Trump administration announced a new plan to limit the out-of-pocket costs for insulin to $35 month for Medicare patients, [...]
Dems Invite Insulin Affordability Advocates to State of the Union
A slate of Democratic legislators have invited insulin affordability activists as their guests to tonight's State of the Union address, [...]
A Look at California’s Plan to Make Generic Drugs
A recent report by The Sacramento Bee takes an in-depth look at California's plan to manufacture its own generic drugs [...]
Dems Pivot to Insulin, Illinois Caps Insulin Prices
Democratic presidential candidates during a campaign stop in Iowa made clear their frustration over U.S. insulin prices, STAT reports. During [...]
Lilly Exec Talks Insulin Market
Pharmalot recently caught up with Mike Mason, head of Eli Lilly's diabetes branch, to discuss the drugmaker's generic alternative to [...]